<DOC>
	<DOCNO>NCT02453529</DOCNO>
	<brief_summary>This Phase 1 , multiple dose , open-label pharmacokinetic study conduct healthy adult male female subject . Subjects receive 3 oral dos WCK 4873 administer once-daily start Day 1 . Blood collection determine plasma WCK 4873 concentration conduct within 15 minute prior 1 , 2 , 3 , 4 , 6 , 9 , 12 , 24 hour first dose WCK 4873 . The 24 hour post-dose sample first dose collected prior Day 2 dosing . Blood sample determine plasma WCK 4873 concentration also collect within 15 minute prior 1 , 2 , 3 , 4 , 6 , 9 , 12 , 24 36 hour third dose . Each subject undergo one standardized bronchoscopy bronchoalveolar lavage ( BAL ) outpatient bronchoscopy suite 3 , 6 , 9 , 12 , 24 48 hour third oral dose WCK 4873 . Subjects schedule bronchoscopy 48 hour also blood sample drawn determine plasma WCK 4873 concentration 48 hour third dose . Safety assess throughout study adverse event monitoring , clinical laboratory test ( include liver function test ) , ECG , physical examination vital sign monitoring . Subjects discontinue study drug administration event AST/ALT elevation great 3 time upper limit normal .</brief_summary>
	<brief_title>Study Determine Compare Plasma Intrapulmonary Concentrations WCK 4873 Healthy Adult Human Subjects</brief_title>
	<detailed_description />
	<criteria>Body mass index ( BMI ) 18.5 30 ( kg/m2 ) weight 55.0 100.0 kg ( inclusive ) . Medical history without major pathology judge Principal Investigator . Resting supine blood pressure 100139 ( systolic ) 6089 ( diastolic ) mm Hg , rest pulse rate 40 beat per minute high , show clinically relevant deviation judge Principal Investigator . History presence significant oncologic , cardiovascular , pulmonary , hepatic , renal , hematological , gastrointestinal , endocrine , immunologic , dermatologic , neurological , psychiatric disease . Positive alcohol breath test urine drug screen test screening confinement . Positive test HIV , Hepatitis B Hepatitis C. Clinically significant pulmonary disease prevents subject undergoing bronchoscopy pulmonary lavage .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>plasma concentration</keyword>
	<keyword>pulmonary concentration</keyword>
</DOC>